Simplification to co-formulated rilpivirine/emtricitabine/tenofovir in virologically suppressed patients: Data from a multicenter cohort

C Pinnetti; Simona Di Giambenedetto; F Maggiolo; P Lorenzini; M Fabbiani; C Tommasi; A Latini; A Ammassari; L Loiacono; G Sterrantino; R Bellagamba; E Boumis; A Antinori; M. Zaccarelli

doi:10.7448/IAS.17.4.19812

Simplification to co-formulated rilpivirine/emtricitabine/tenofovir in virologically suppressed patients: Data from a multicenter cohort

C Pinnetti, Simona Di Giambenedetto, F Maggiolo, P Lorenzini, M Fabbiani, C Tommasi, A Latini, A Ammassari, L Loiacono, G Sterrantino, R Bellagamba, E Boumis, A Antinori, M. Zaccarelli

Risultato della ricerca: Contributo in rivista › Articolo di conferenza › peer review

Abstract

To assess efficacy and safety of treatment simplification to co-formulated Rilpivirine/Emtricitabine/Tenofovir (RPV/FTC/TDF) in virologically suppressed patients.

Lingua originale	Inglese
pagine (da-a)	19812-19812
Numero di pagine	1
Rivista	Journal of the International AIDS Society
Volume	17
DOI	https://doi.org/10.7448/IAS.17.4.19812
Stato di pubblicazione	Pubblicato - 2014
Evento	HIV Drug Therapy Glasgow Congress 2014 - Glasgow Durata: 2 nov 2014 → 6 nov 2014

Keywords

HIV
simplification
therapy

OSS delle Nazioni Unite

Questo processo contribuisce al raggiungimento dei seguenti obiettivi di sviluppo sostenibile

Accesso al documento

10.7448/IAS.17.4.19812

Altri file e collegamenti

Link a IRIS PubliCatt

Cita questo

Pinnetti, C., Di Giambenedetto, S., Maggiolo, F., Lorenzini, P., Fabbiani, M., Tommasi, C., Latini, A., Ammassari, A., Loiacono, L., Sterrantino, G., Bellagamba, R., Boumis, E., Antinori, A., & Zaccarelli, M. (2014). Simplification to co-formulated rilpivirine/emtricitabine/tenofovir in virologically suppressed patients: Data from a multicenter cohort. Journal of the International AIDS Society, 17, 19812-19812. https://doi.org/10.7448/IAS.17.4.19812

@article{f65c8b1468454ab892fe0e02f7e4d07b,

title = "Simplification to co-formulated rilpivirine/emtricitabine/tenofovir in virologically suppressed patients: Data from a multicenter cohort",

abstract = "To assess efficacy and safety of treatment simplification to co-formulated Rilpivirine/Emtricitabine/Tenofovir (RPV/FTC/TDF) in virologically suppressed patients.",

keywords = "HIV, simplification, therapy, HIV, simplification, therapy",

author = "C Pinnetti and {Di Giambenedetto}, Simona and F Maggiolo and P Lorenzini and M Fabbiani and C Tommasi and A Latini and A Ammassari and L Loiacono and G Sterrantino and R Bellagamba and E Boumis and A Antinori and M. Zaccarelli",

year = "2014",

doi = "10.7448/IAS.17.4.19812",

language = "English",

volume = "17",

pages = "19812--19812",

journal = "Journal of the International AIDS Society",

issn = "1758-2652",

publisher = "John Wiley & Sons Inc.",

note = "HIV Drug Therapy Glasgow Congress 2014 ; Conference date: 02-11-2014 Through 06-11-2014",

}

Pinnetti, C, Di Giambenedetto, S, Maggiolo, F, Lorenzini, P, Fabbiani, M, Tommasi, C, Latini, A, Ammassari, A, Loiacono, L, Sterrantino, G, Bellagamba, R, Boumis, E, Antinori, A & Zaccarelli, M 2014, 'Simplification to co-formulated rilpivirine/emtricitabine/tenofovir in virologically suppressed patients: Data from a multicenter cohort', Journal of the International AIDS Society, vol. 17, pagg. 19812-19812. https://doi.org/10.7448/IAS.17.4.19812

TY - JOUR

T1 - Simplification to co-formulated rilpivirine/emtricitabine/tenofovir in virologically suppressed patients: Data from a multicenter cohort

AU - Pinnetti, C

AU - Di Giambenedetto, Simona

AU - Maggiolo, F

AU - Lorenzini, P

AU - Fabbiani, M

AU - Tommasi, C

AU - Latini, A

AU - Ammassari, A

AU - Loiacono, L

AU - Sterrantino, G

AU - Bellagamba, R

AU - Boumis, E

AU - Antinori, A

AU - Zaccarelli, M.

PY - 2014

Y1 - 2014

N2 - To assess efficacy and safety of treatment simplification to co-formulated Rilpivirine/Emtricitabine/Tenofovir (RPV/FTC/TDF) in virologically suppressed patients.

AB - To assess efficacy and safety of treatment simplification to co-formulated Rilpivirine/Emtricitabine/Tenofovir (RPV/FTC/TDF) in virologically suppressed patients.

KW - HIV

KW - simplification

KW - therapy

KW - HIV

KW - simplification

KW - therapy

UR - http://hdl.handle.net/10807/61293

U2 - 10.7448/IAS.17.4.19812

DO - 10.7448/IAS.17.4.19812

M3 - Conference article

SN - 1758-2652

VL - 17

SP - 19812

EP - 19812

JO - Journal of the International AIDS Society

JF - Journal of the International AIDS Society

T2 - HIV Drug Therapy Glasgow Congress 2014

Y2 - 2 November 2014 through 6 November 2014

ER -

Simplification to co-formulated rilpivirine/emtricitabine/tenofovir in virologically suppressed patients: Data from a multicenter cohort

Abstract

Keywords

OSS delle Nazioni Unite

Accesso al documento

Altri file e collegamenti

Fingerprint

Cita questo